Literature DB >> 16713008

20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans.

Natalie C Ward1, Jonathan M Hodgson, Ian B Puddey, Lawrence J Beilin, Kevin D Croft.   

Abstract

Hypertension is often associated with insulin resistance or hyperinsulinemia. Metabolism of arachidonic acid by cytochrome P450 to the vasoconstrictor 20-HETE is thought to be involved in the pathogenesis of hypertension, but the relationship of 20-HETE with insulin resistance is not clearly understood. Obesity is a major determinant of insulin resistance, and we have previously demonstrated a positive relationship between BMI and 20-HETE in untreated hypertensive and normotensive individuals. The present analysis sought to determine if this relationship was related to insulin levels or insulin resistance (HOMA). We analysed 24h urinary excretion of 20-HETE, serum insulin levels and insulin resistance in 66 lean to overweight untreated hypertensive and normotensive individuals. There was a significant positive association between 20-HETE and BMI (p<0.001), and serum insulin and BMI (p=0.003). There were no associations between 20-HETE excretion and either serum insulin or insulin resistance, before or after adjustment for age, gender, BMI and BP, or when hypertensive and normotensive individuals were considered separately. The results of the present study suggest that the observed positive association between urinary 20-HETE excretion and BMI may not be related to circulating insulin levels or insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713008     DOI: 10.1016/j.diabres.2006.04.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

2.  Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia.

Authors:  Yossi Issan; Edith Hochhauser; Austin Guo; Katherine H Gotlinger; Ran Kornowski; Dorit Leshem-Lev; Eli Lev; Eyal Porat; Eitan Snir; Carl I Thompson; Nader G Abraham; Michal Laniado-Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-01-03       Impact factor: 3.072

3.  Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats.

Authors:  Harish Vasudevan; Violet G Yuen; John H McNeill
Journal:  Mol Cell Biochem       Date:  2011-09-06       Impact factor: 3.396

4.  High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE.

Authors:  Ankit Gilani; Varunkumar Pandey; Victor Garcia; Kevin Agostinucci; Shailendra P Singh; Joseph Schragenheim; Lars Bellner; John R Falck; Mahesh P Paudyal; Jorge H Capdevila; Nader G Abraham; Michal Laniado Schwartzman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-08       Impact factor: 3.619

Review 5.  20-HETE in the regulation of vascular and cardiac function.

Authors:  Petra Rocic; Michal Laniado Schwartzman
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

6.  Cyclooxygenase-2 dependent metabolism of 20-HETE increases adiposity and adipocyte enlargement in mesenchymal stem cell-derived adipocytes.

Authors:  Dong Hyun Kim; Nitin Puri; Komal Sodhi; John R Falck; Nader G Abraham; Joseph Shapiro; Michal L Schwartzman
Journal:  J Lipid Res       Date:  2013-01-04       Impact factor: 5.922

7.  20-HETE interferes with insulin signaling and contributes to obesity-driven insulin resistance.

Authors:  Ankit Gilani; Kevin Agostinucci; Sakib Hossain; Jonathan V Pascale; Victor Garcia; Adeniyi Michael Adebesin; John R Falck; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-10-01       Impact factor: 3.072

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.